Candriam SCA’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-101,337
Closed -$266K 781
2023
Q1
$266K Buy
+101,337
New +$266K ﹤0.01% 859